Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.20.2
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 45,998 $ 100,862 $ 88,008,473 $ 4,759 $ (87,835,132) $ 324,960
Beginning balance, shares at Dec. 31, 2018 45,998,053          
Issuance of common stock for cash $ 2,800 2,797,200 2,800,000
Issuance of common stock for cash, shares 2,800,000          
Issuance of common stock for debt conversion $ 2,583 2,812,795 $ 2,815,378
Issuance of common stock for debt conversion, shares 2,582,916          
Issuance of common stock for option exercise, shares          
Stock based compensation 1,163,270 $ 1,163,270
Foreign currency translation adjustment 4,021 4,021
Net loss (8,821,974) (8,821,974)
Ending balance, value at Dec. 31, 2019 $ 51,381 100,862 94,781,738 8,780 (96,657,106) (1,714,345)
Ending balance, shares at Dec. 31, 2019 51,380,969          
Issuance of common stock for option exercise $ 15 7,185 $ 7,200
Issuance of common stock for option exercise, shares 15,000         15,000
Issuance of common stock for warrant exercise $ 235 234,265 $ 234,500
Issuance of common stock for warrant exercise, shares 234,500          
Stock based compensation 509,214 509,214
Foreign currency translation adjustment (9,072) (9,072)
Net loss (1,701,671) (1,701,671)
Ending balance, value at Sep. 30, 2020 $ 51,631 $ 100,862 $ 95,532,402 $ (292) $ (98,358,777) $ (2,674,174)
Ending balance, shares at Sep. 30, 2020 51,630,469